Is Viking Therapeutics Incredibly Undervalued?

The biotech's weight loss drug candidate could fuel a premium-laden buyout, but risks abound.

Related Keywords

Andy Hsieh ,William Blair ,Eli Lilly ,Pfizer ,Goldman Sachs ,Novo Nordisk ,Viking Therapeutics ,Image Source ,Wall Street ,Leerink Partners ,Viking Therapeutic ,